Invention Grant
- Patent Title: Glycosidase inhibitors
-
Application No.: US15507375Application Date: 2015-08-27
-
Publication No.: US10336775B2Publication Date: 2019-07-02
- Inventor: Anna Quattropani , Santosh S. Kulkarni , Awadut Gajendra Giri
- Applicant: Asceneuron SA
- Applicant Address: CH Lausanne
- Assignee: Asceneuron SA
- Current Assignee: Asceneuron SA
- Current Assignee Address: CH Lausanne
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Thomas J. Paxton
- Priority: IN2766/MUM/2014 20140828
- International Application: PCT/EP2015/069598 WO 20150827
- International Announcement: WO2016/030443 WO 20160303
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D513/04 ; C07D403/12 ; C07D413/14 ; A61K31/454 ; A61K31/496 ; A61K31/497 ; A61K31/498 ; A61K31/501 ; A61K31/506 ; A61K31/5377 ; C07D401/12 ; C07D405/12 ; C07D413/12 ; C07D417/12 ; C07D417/14 ; C07D487/04 ; C07D285/135 ; A61K45/06 ; A61K31/517 ; A61K31/519 ; C07D277/46
Abstract:
The disclosure relates to compounds of formula (I) useful in the treatment of tauopathies and Alzheimer's disease wherein A, R, W, Q, n, and m are described herein.
Public/Granted literature
- US20170298082A1 GLYCOSIDASE INHIBITORS Public/Granted day:2017-10-19
Information query
